CircHIPK3 Promotes the Tumorigenesis and Development of Gastric Cancer Through miR-637/AKT1 Pathway

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Circular RNAs (circRNAs) are implicated in tumorigenesis and metastasis.
• The specific role of circRNAs in gastric cancer (GC) remains largely unknown.
• Understanding circRNA function is crucial for developing novel cancer therapies.

Purpose of the Study:

• To investigate the role and mechanism of circHIPK3 in gastric cancer.
• To elucidate the regulatory pathway involving circHIPK3, miR-637, and AKT1 in GC.
• To assess the therapeutic potential of targeting circHIPK3 in GC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to measure circHIPK3 expression in GC tissues and cell lines.
• Bioinformatics analysis and dual-luciferase reporter assays to predict and validate miRNA targets.
• In vitro experiments to assess the effects of circHIPK3 modulation on GC cell proliferation and metabolism.

Main Results:

• CircHIPK3 expression was significantly increased in GC tissues and cell lines.
• CircHIPK3 acts as a molecular sponge for miR-637, thereby releasing its direct target, AKT1.
• Overexpression of circHIPK3 led to decreased miR-637 levels and increased AKT1 levels, promoting GC cell growth.
• Downregulation of miR-637 or upregulation of AKT1 attenuated the anti-proliferative effects of circHIPK3 inhibition.

Conclusions:

• The circHIPK3/miR-637/AKT1 regulatory pathway plays a significant role in the tumorigenesis and progression of gastric cancer.
• CircHIPK3 functions as an oncogenic circRNA in GC by modulating the miR-637/AKT1 axis.
• Targeting circHIPK3 represents a potential therapeutic strategy for gastric cancer treatment.